Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,158 | -50,677 | -31,119 | -21,576 | -114,752 |
| Depreciation Amortization | 576 | 357 | 237 | 116 | 431 |
| Accounts receivable | 2,379 | 2,056 | 1,541 | 1,440 | -2,864 |
| Accounts payable and accrued liabilities | -2,096 | -1,852 | -3,187 | -1,707 | 2,751 |
| Other Working Capital | -1,320 | -2,763 | -5,678 | -405 | 4,308 |
| Other Operating Activity | 12,991 | 9,676 | 8,010 | 3,238 | 12,076 |
| Operating Cash Flow | $-59,628 | $-43,203 | $-30,196 | $-18,894 | $-98,050 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -204 | -105 | -88 | -83 | -771 |
| Purchase Sale Intangibles | -4,750 | -3,000 | N/A | N/A | N/A |
| Other Investing Activity | -4,750 | -3,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-4,954 | $-3,105 | $-88 | $-83 | $-771 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,949 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 7,498 | 7,356 | 5,075 | 231 | 93,146 |
| Financing Cash Flow | $36,447 | $7,356 | $5,075 | $231 | $93,146 |
| Beginning Cash Position | 136,610 | 136,610 | 136,610 | 136,610 | 142,285 |
| End Cash Position | 108,475 | 97,658 | 111,401 | 117,864 | 136,610 |
| Net Cash Flow | $-28,135 | $-38,952 | $-25,209 | $-18,746 | $-5,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,628 | -43,203 | -30,196 | -18,894 | -98,050 |
| Capital Expenditure | -204 | -105 | -88 | -83 | -771 |
| Free Cash Flow | -59,832 | -43,308 | -30,284 | -18,977 | -98,821 |